BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Smith JO, Sterling RK. Systematic review: non-invasive methods of fibrosis analysis in chronic hepatitis C. Alimentary Pharmacology & Therapeutics 2009;30:557-76. [DOI: 10.1111/j.1365-2036.2009.04062.x] [Cited by in Crossref: 86] [Cited by in F6Publishing: 86] [Article Influence: 6.6] [Reference Citation Analysis]
Number Citing Articles
1 Clark PJ, Patel K. Noninvasive tools to assess liver disease. Curr Opin Gastroenterol. 2011;27:210-216. [PMID: 21248634 DOI: 10.1097/MOG.0b013e328343e9a3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
2 Friedman SL. Focus. J Hepatol 2011;55:503-4. [PMID: 21621571 DOI: 10.1016/j.jhep.2011.05.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
3 Salvatore V, Borghi A, Peri E, Colecchia A, Li Bassi S, Montrone L, Di Donato R, Conti F, Crespi C, Festi D, Bernardi M, Andreone P, Bolondi L. Relationship between hepatic haemodynamics assessed by Doppler ultrasound and liver stiffness. Digestive and Liver Disease 2012;44:154-9. [DOI: 10.1016/j.dld.2011.08.021] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
4 Moustafa EF, Makhlouf N, Hassany SM, Helmy A, Nasr A, Othman M, Seif H, Darwish M, Hassan H, Hessen M. Non-invasive assessment of liver fibrosis in patients with hepatitis C: Shear wave elastography and colour Doppler velocity profile technique versus liver biopsy. Arab Journal of Gastroenterology 2017;18:6-12. [DOI: 10.1016/j.ajg.2017.01.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
5 Kobayashi K, Nakao H, Nishiyama T, Lin Y, Kikuchi S, Kobayashi Y, Yamamoto T, Ishii N, Ohashi T, Satoh K. Diagnostic accuracy of real-time tissue elastography for the staging of liver fibrosis: a meta-analysis. Eur Radiol. 2015;25:230-238. [PMID: 25149296 DOI: 10.1007/s00330-014-3364-x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 4.1] [Reference Citation Analysis]
6 Friedrich-Rust M, Buggisch P, de Knegt RJ, Dries V, Shi Y, Matschenz K, Schneider MD, Herrmann E, Petersen J, Schulze F, Zeuzem S, Sarrazin C. Acoustic radiation force impulse imaging for non-invasive assessment of liver fibrosis in chronic hepatitis B. J Viral Hepat. 2013;20:240-247. [PMID: 23490368 DOI: 10.1111/j.1365-2893.2012.01646.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 4.5] [Reference Citation Analysis]
7 Fernandes FF, Ferraz ML, Andrade LE, Dellavance A, Terra C, Pereira G, Pereira JL, Campos F, Figueiredo F, Perez RM. Enhanced liver fibrosis panel as a predictor of liver fibrosis in chronic hepatitis C patients. J Clin Gastroenterol. 2015;49:235-241. [PMID: 24714186 DOI: 10.1097/mcg.0000000000000128] [Cited by in Crossref: 28] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
8 Kishore R, Loomba R, Sterling RK. Editorial: A New Spin on Magnetic Resonance Elastography. American Journal of Gastroenterology 2016;111:834-7. [DOI: 10.1038/ajg.2016.134] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
9 García-compeán D, Villarreal-pérez JZ, Cavazos MEDLO, Lavalle-gonzalez FJ, Borjas-almaguer OD, Del Cueto-aguilera AN, González-gonzález JA, Treviño-garza C, Huerta-pérez L, Maldonado-garza HJ. Prevalence of liver fibrosis in an unselected general population with high prevalence of obesity and diabetes mellitus. Time for screening? Annals of Hepatology 2020;19:258-64. [DOI: 10.1016/j.aohep.2020.01.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Sebastiani G, Halfon P, Castera L, Mangia A, Di Marco V, Pirisi M, Voiculescu M, Bourliere M, Alberti A. Comparison of three algorithms of non-invasive markers of fibrosis in chronic hepatitis C: Combination algorithms for liver fibrosis in HCV. Alimentary Pharmacology & Therapeutics 2012;35:92-104. [DOI: 10.1111/j.1365-2036.2011.04897.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 3.0] [Reference Citation Analysis]
11 Ellis EL, Mann DA. Clinical evidence for the regression of liver fibrosis. J Hepatol. 2012;56:1171-1180. [PMID: 22245903 DOI: 10.1016/j.jhep.2011.09.024] [Cited by in Crossref: 253] [Cited by in F6Publishing: 243] [Article Influence: 25.3] [Reference Citation Analysis]
12 Hannivoort RA, Hernandez-Gea V, Friedman SL. Genomics and proteomics in liver fibrosis and cirrhosis. Fibrogenesis Tissue Repair 2012;5:1. [PMID: 22214245 DOI: 10.1186/1755-1536-5-1] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
13 Patel K. Noninvasive tools to assess liver disease. Curr Opin Gastroenterol. 2010;26:227-233. [PMID: 20179592 DOI: 10.1097/MOG.0b013e3283383c68] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
14 Fallowfield J, Hayes P. Pathogenesis and treatment of hepatic fibrosis: is cirrhosis reversible? Clin Med (Lond) 2011;11:179-83. [PMID: 21526707 DOI: 10.7861/clinmedicine.11-2-179] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
15 Diktas H, Karacaer Z, Özturk II, Cicek H. Comparison of relationship between histopathological, serological and biochemical parameters in patients with chronic hepatitis B infection. Postgrad Med J 2016;92:693-6. [PMID: 27170311 DOI: 10.1136/postgradmedj-2016-134069] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
16 Li C, Zhang C, Li J, Huo H, Song D. Diagnostic Accuracy of Real-Time Shear Wave Elastography for Staging of Liver Fibrosis: A Meta-Analysis. Med Sci Monit 2016;22:1349-59. [PMID: 27102449 DOI: 10.12659/msm.895662] [Cited by in Crossref: 33] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
17 Nierhoff J, Chávez Ortiz AA, Herrmann E, Zeuzem S, Friedrich-rust M. The efficiency of acoustic radiation force impulse imaging for the staging of liver fibrosis: a meta-analysis. Eur Radiol 2013;23:3040-53. [DOI: 10.1007/s00330-013-2927-6] [Cited by in Crossref: 120] [Cited by in F6Publishing: 103] [Article Influence: 13.3] [Reference Citation Analysis]
18 Eminler AT, Uslan MI, Ayyildiz T, Irak K, Kiyici M, Gurel S, Dolar E, Gulten M, Nak SG. Mean platelet volume is an important predictor of hepatitis C but not hepatitis B liver damage. J Res Med Sci 2015;20:865-70. [PMID: 26759574 DOI: 10.4103/1735-1995.170609] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
19 Alswat KA, Mumtaz K, Jafri W. Liver biopsy for histological assessment: The case in favor. Saudi J Gastroenterol 2010;16:133-9. [PMID: 20339188 DOI: 10.4103/1319-3767.61245] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
20 Friedman SL. Evolving challenges in hepatic fibrosis. Nat Rev Gastroenterol Hepatol. 2010;7:425-436. [PMID: 20585339 DOI: 10.1038/nrgastro. 2010.97] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Kim AY. Management algorithm for genotype 1 hepatitis C virus. F1000Prime Rep 2013;5:24. [PMID: 23864931 DOI: 10.12703/P5-24] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
22 Hoshida Y, Villanueva A, Sangiovanni A, Sole M, Hur C, Andersson KL, Chung RT, Gould J, Kojima K, Gupta S, Taylor B, Crenshaw A, Gabriel S, Minguez B, Iavarone M, Friedman SL, Colombo M, Llovet JM, Golub TR. Prognostic gene expression signature for patients with hepatitis C-related early-stage cirrhosis. Gastroenterology 2013;144:1024-30. [PMID: 23333348 DOI: 10.1053/j.gastro.2013.01.021] [Cited by in Crossref: 125] [Cited by in F6Publishing: 121] [Article Influence: 13.9] [Reference Citation Analysis]
23 Wen X, Wang XM, Wang BY. Recent advances in the use of Fibroscan for diagnosis of liver fibrosis. Shijie Huaren Xiaohua Zazhi 2009; 17(31): 3223-3228 [DOI: 10.11569/wcjd.v17.i31.3223] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
24 Tran HA, Jones TL, Ianna EA, Foy A, Reeves GE. Thyroid disease in chronic hepatitis C infection treated with combination interferon-α and ribavirin: management strategies and future perspective. Endocr Pract 2013;19:292-300. [PMID: 23186968 DOI: 10.4158/EP12195.RA] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
25 Bracht T, Mölleken C, Ahrens M, Poschmann G, Schlosser A, Eisenacher M, Stühler K, Meyer HE, Schmiegel WH, Holmskov U, Sorensen GL, Sitek B. Evaluation of the biomarker candidate MFAP4 for non-invasive assessment of hepatic fibrosis in hepatitis C patients. J Transl Med 2016;14:201. [PMID: 27378383 DOI: 10.1186/s12967-016-0952-3] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 4.3] [Reference Citation Analysis]
26 Enache EL, Sin A, Enache LS, Bancu L. Triplex High-Resolution Melting Assay for the Simultaneous Assessment of IFNL3 rs12979860, ABCB11 rs2287622, and RNF7 rs16851720 Genotypes in Chronic Hepatitis C Patients. J Mol Diagn 2017;19:857-69. [PMID: 28860020 DOI: 10.1016/j.jmoldx.2017.07.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
27 Van Gossum A, Pironi L, Messing B, Moreno C, Colecchia A, D’errico A, Demetter P, De Gos F, Cazals-halem D, Joly F. Transient Elastography (FibroScan) Is Not Correlated With Liver Fibrosis but With Cholestasis in Patients With Long-Term Home Parenteral Nutrition. JPEN J Parenter Enteral Nutr 2014;39:719-24. [DOI: 10.1177/0148607114538057] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 5.3] [Reference Citation Analysis]
28 Singal AG, Thomassen LV, Gretch DR, Shuhart MC. Use of the AST to platelet ratio index in HCV/HIV co-infected patients. Aliment Pharmacol Ther. 2011;33:566-577. [PMID: 21205257 DOI: 10.1111/j.1365-2036.2010.04560.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
29 Kayadibi H, Yasar B, Ozkara S, Serdar MA, Kurdas OO, Gonen C. The diagnostic accuracy of the Forns index, platelet count and AST to Platelet Ratio Index derived fibrosis index for the prediction of Hepatitis C virus-related significant liver fibrosis and cirrhosis. Scand J Clin Lab Invest. 2014;74:240-247. [PMID: 24460024 DOI: 10.3109/00365513.2013.879392] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
30 Bello DD, Ita-nagy F, Hand J, Dieterich D. Treatment of hepatitis C in coinfected patients. Future Virology 2015;10:1291-305. [DOI: 10.2217/fvl.15.99] [Reference Citation Analysis]
31 Orozco F, Post ZD, Baxi O, Miller A, Ong A. Fibrosis in hepatitis C patients predicts complications after elective total joint arthroplasty. J Arthroplasty 2014;29:7-10. [PMID: 23648106 DOI: 10.1016/j.arth.2013.03.023] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 3.8] [Reference Citation Analysis]
32 Aktug Demir N, Kolgelier S, Ozcimen S, Gungor G, Sumer S, Saltuk Demir L, Inkaya AC, Ural O. Evaluation of the relation between hepatic fibrosis and basic laboratory parameters in patients with chronic hepatitis B fibrosis and basic laboratory parameters. Hepat Mon 2014;14:e16975. [PMID: 24748897 DOI: 10.5812/hepatmon.16975] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
33 Leão J, Brock M, Castilho M, Scariot A, Scariot A, Braga W. Non-invasive assessment of fibrosis using color Doppler ultrasound in patients with hepatitis C virus in the Amazon rainforest, Brazil. Am J Trop Med Hyg 2012;86:273-9. [PMID: 22302863 DOI: 10.4269/ajtmh.2012.11-0561] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
34 Gaia S, Campion D, Evangelista A, Spandre M, Cosso L, Brunello F, Ciccone G, Bugianesi E, Rizzetto M. Non-invasive score system for fibrosis in chronic hepatitis: proposal for a model based on biochemical, FibroScan and ultrasound data. Liver Int 2015;35:2027-35. [PMID: 25495478 DOI: 10.1111/liv.12761] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
35 Alavian SM, Hajarizadeh B, Bagheri Lankarani K, Sharafi H, Ebrahimi Daryani N, Merat S, Mohraz M, Mardani M, Fattahi MR, Poustchi H. Recommendations for the Clinical Management of Hepatitis C in Iran: A Consensus-Based National Guideline. Hepat Mon. 2016;16:e40959. [PMID: 27799966 DOI: 10.5812/hepatmon.guideline] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 7.0] [Reference Citation Analysis]
36 Hoshida Y, Fuchs BC, Bardeesy N, Baumert TF, Chung RT. Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma. J Hepatol. 2014;61:S79-S90. [PMID: 25443348 DOI: 10.1016/j.jhep.2014.07.010] [Cited by in Crossref: 124] [Cited by in F6Publishing: 110] [Article Influence: 15.5] [Reference Citation Analysis]
37 Jain MK, Seremba E, Bhore R, Dao D, Joshi R, Attar N, Yuan HJ, Lee WM. Change in fibrosis score as a predictor of mortality among HIV-infected patients with viral hepatitis. AIDS Patient Care STDS 2012;26:73-80. [PMID: 22239101 DOI: 10.1089/apc.2011.0191] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
38 Friedman SL. Evolving challenges in hepatic fibrosis. Nat Rev Gastroenterol Hepatol 2010;7:425-36. [DOI: 10.1038/nrgastro.2010.97] [Cited by in Crossref: 377] [Cited by in F6Publishing: 379] [Article Influence: 31.4] [Reference Citation Analysis]
39 Goossens N, Hoshida Y. Hepatitis C virus-induced hepatocellular carcinoma. Clin Mol Hepatol. 2015;21:105-114. [PMID: 26157746 DOI: 10.3350/cmh.2015.21.2.105] [Cited by in Crossref: 80] [Cited by in F6Publishing: 74] [Article Influence: 11.4] [Reference Citation Analysis]
40 Tama M, Naylor P, Patel S, Altawil J, Gulati D, Antaki F, Mutchnick MG, Ehrinpreis M. Overestimate of Fibrosis by FIBROSpect® II in African Americans Complicates the Management of their Chronic Hepatitis C. J Clin Transl Hepatol 2016;4:12-9. [PMID: 27047767 DOI: 10.14218/JCTH.2015.00053] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
41 Theise ND, Bodenheimer HC, Ferrell LD. Acute and chronic viral hepatitis. MacSween's Pathology of the Liver. Elsevier; 2012. pp. 361-401. [DOI: 10.1016/b978-0-7020-3398-8.00007-6] [Cited by in Crossref: 6] [Article Influence: 0.6] [Reference Citation Analysis]
42 Sekimoto T, Maruyama H, Kondo T, Shimada T, Takahashi M, Yokosuka O, Otsuka M, Miyazaki M, Mine Y. Virtual laparoscopy: Initial experience with three-dimensional ultrasonography to characterize hepatic surface features. European Journal of Radiology 2013;82:929-34. [DOI: 10.1016/j.ejrad.2013.01.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
43 Sebastiani G, Castera L, Halfon P, Pol S, Mangia A, Di Marco V, Pirisi M, Voiculescu M, Bourliere M, Alberti A. The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of 2411 cases: Liver fibrosis biomarkers, aetiology and fibrosis stages. Alimentary Pharmacology & Therapeutics 2011;34:1202-16. [DOI: 10.1111/j.1365-2036.2011.04861.x] [Cited by in Crossref: 86] [Cited by in F6Publishing: 83] [Article Influence: 7.8] [Reference Citation Analysis]
44 Kim BK, Park YN, Kim DY, Park JY, Chon CY, Han K, Ahn SH. Risk Assessment of Development of Hepatic Decompensation in Histologically Proven Hepatitis B Viral Cirrhosis Using Liver Stiffness Measurement. Digestion 2012;85:219-27. [DOI: 10.1159/000335430] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
45 Friedman SL. Hepatic Fibrosis. In: Schiff ER, Maddrey WC, Sorrell MF, editors. Schiff's Diseases of the Liver. Oxford: Wiley-Blackwell; 2011. pp. 295-315. [DOI: 10.1002/9781119950509.ch12] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
46 Elalfy MS, Esmat G, Matter RM, Abdel Aziz HE, Massoud WA. Liver fibrosis in young Egyptian beta-thalassemia major patients: relation to hepatitis C virus and compliance with chelation. Annals of Hepatology 2013;12:54-61. [DOI: 10.1016/s1665-2681(19)31385-7] [Cited by in Crossref: 11] [Article Influence: 1.2] [Reference Citation Analysis]
47 Nguyen TAT, Sterling RK. Measuring Fibrosis: Is Seeing Really Believing? Dig Dis Sci 2012;57:1983-6. [DOI: 10.1007/s10620-012-2278-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
48 Parkes J, Guha IN, Harris S, Rosenberg WM, Roderick PJ. Systematic review of the diagnostic performance of serum markers of liver fibrosis in alcoholic liver disease. Comp Hepatol. 2012;11:5. [PMID: 23273224 DOI: 10.1186/1476-5926-11-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
49 Rocco A, de Nucci G, Valente G, Compare D, D’arienzo A, Cimino L, Perri F, Nardone G. 13C-Aminopyrine breath test accurately predicts long-term outcome of chronic hepatitis C. Journal of Hepatology 2012;56:782-7. [DOI: 10.1016/j.jhep.2011.10.015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
50 Mohamed Z, Rwegasha J, Kim JU, Shimakawa Y, Poiteau L, Chevaliez S, Bhagani S, Taylor-Robinson SD, Thursz MR, Mbwambo J, Lemoine M. The hepatitis C cascade of care in people who inject drugs in Dar es Salaam, Tanzania. J Viral Hepat 2018;25:1438-45. [PMID: 29974582 DOI: 10.1111/jvh.12966] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
51 Salomon RE, Tan KR, Vaughan A, Adynski H, Muscatell KA. Minimally-invasive methods for examining biological changes in response to chronic stress: A scoping review. Int J Nurs Stud 2020;103:103419. [PMID: 31945603 DOI: 10.1016/j.ijnurstu.2019.103419] [Reference Citation Analysis]
52 Martel-Laferrière V, Wong M, Dieterich DT. HIV/hepatitis C virus-coinfected patients and cirrhosis: how to diagnose it and what to do next? Clin Infect Dis 2014;58:840-7. [PMID: 24178247 DOI: 10.1093/cid/cit714] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
53 Mangia A, Dalgard O, Minerva N, Verbaan H, Bacca D, Ring-larsen H, Copetti M, Carretta V, Piazzolla V, Cozzolongo R, Mottola L, Andriulli A. Ribavirin dosage in patients with HCV genotypes 2 and 3 who completed short therapy with peg-interferon α-2b and ribavirin: RIBAVIRIN DOSE IN SHORT THERAPY FOR PATIENTS WITH HCV GENOTYPES 2 AND 3 INFECTION. Alimentary Pharmacology & Therapeutics 2010;31:1346-53. [DOI: 10.1111/j.1365-2036.2010.04290.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
54 Poynard T, Munteanu M, Ngo Y, Ratziu V. Appropriate evidence-based data overviews demonstrate the diagnostic and prognostic performances of FibroTest in patients with chronic hepatitis C. Aliment Pharmacol Ther 2009;30:1183-5; author reply 1185-6. [PMID: 19888919 DOI: 10.1111/j.1365-2036.2009.04115.x] [Reference Citation Analysis]
55 Brown A, Goodman Z. Hepatitis B-associated fibrosis and fibrosis/cirrhosis regression with nucleoside and nucleotide analogs. Expert Review of Gastroenterology & Hepatology 2014;6:187-98. [DOI: 10.1586/egh.12.4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
56 Kim BK, Fung J, Yuen MF, Kim SU. Clinical application of liver stiffness measurement using transient elastography in chronic liver disease from longitudinal perspectives. World J Gastroenterol 2013; 19(12): 1890-1900 [PMID: 23569334 DOI: 10.3748/wjg.v19.i12.1890] [Cited by in CrossRef: 57] [Cited by in F6Publishing: 53] [Article Influence: 6.3] [Reference Citation Analysis]
57 Meijer K, Haagsma EB. HCV-related liver cancer in people with haemophilia: HCV-RELATED LIVER CANCER IN HAEMOPHILIA. Haemophilia 2012;18:17-24. [DOI: 10.1111/j.1365-2516.2011.02575.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
58 Acharya C, Dharel N, Sterling RK. Chronic liver disease in the human immunodeficiency virus patient. Clin Liver Dis 2015;19:1-22. [PMID: 25454294 DOI: 10.1016/j.cld.2014.09.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
59 Kang W, Kim SU, Ahn SH. Non-invasive prediction of forthcoming cirrhosis-related complications. World J Gastroenterol 2014; 20(10): 2613-2623 [PMID: 24627597 DOI: 10.3748/wjg.v20.i10.2613] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
60 Golizeh M, Melendez-Pena CE, Ward BJ, Saeed S, Santamaria C, Conway B, Cooper C, Klein MB, Ndao M; Canadian Co-Infection Cohort (CTN222). Proteomic fingerprinting in HIV/HCV co-infection reveals serum biomarkers for the diagnosis of fibrosis staging. PLoS One 2018;13:e0195148. [PMID: 29608613 DOI: 10.1371/journal.pone.0195148] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
61 Friedrich-Rust M, Nierhoff J, Lupsor M, Sporea I, Fierbinteanu-Braticevici C, Strobel D, Takahashi H, Yoneda M, Suda T, Zeuzem S, Herrmann E. Performance of Acoustic Radiation Force Impulse imaging for the staging of liver fibrosis: a pooled meta-analysis. J Viral Hepat. 2012;19:e212-e219. [PMID: 22239521 DOI: 10.1111/j.1365-2893.2011.01537.x] [Cited by in Crossref: 312] [Cited by in F6Publishing: 282] [Article Influence: 28.4] [Reference Citation Analysis]
62 Patel K, Friedrich-Rust M, Lurie Y, Grigorescu M, Stanciu C, Lee CM, Schiff ER, Häussinger D, Manns MP, Gerken G, Colle I, Torbenson M, Pulkstenis E, Subramanian GM, McHutchison JG, Zeuzem S. FibroSURE and FibroScan® in relation to treatment response in chronic hepatitis C virus. World J Gastroenterol 2011; 17(41): 4581-4589 [PMID: 22147963 DOI: 10.3748/wjg.v17.i41.4581] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
63 Siddiqui MS, Patidar KR, Boyett S, Smith PG, Sanyal AJ, Sterling RK. Validation of noninvasive methods for detecting hepatic steatosis in patients with human immunodeficiency virus infection. Clin Gastroenterol Hepatol 2015;13:402-5. [PMID: 25004459 DOI: 10.1016/j.cgh.2014.06.027] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
64 da Silva Franco KMV, Vieira WB, Dias ARN, Falcão ASC, Falcão LFM, Quaresma JAS. Doppler ultrasonography: A non-invasive method used to diagnose and follow up patients with chronic hepatitis C. J Gastroenterol Hepatol 2020;35:314-9. [PMID: 31335991 DOI: 10.1111/jgh.14793] [Reference Citation Analysis]
65 Cheng JC, Tseng CP, Liao MH, Peng CY, Yu JS, Chuang PH, Huang JT, Chen JJW. Activation of hepatic stellate cells by the ubiquitin C-terminal hydrolase 1 protein secreted from hepatitis C virus-infected hepatocytes. Sci Rep 2017;7:4448. [PMID: 28667290 DOI: 10.1038/s41598-017-04259-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
66 Lagging M, Duberg AS, Wejstål R, Weiland O, Lindh M, Aleman S, Josephson F; Swedish Consensus Group. Treatment of hepatitis C virus infection in adults and children: updated Swedish consensus recommendations. Scand J Infect Dis 2012;44:502-21. [PMID: 22506634 DOI: 10.3109/00365548.2012.669045] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
67 King LY, Canasto-Chibuque C, Johnson KB, Yip S, Chen X, Kojima K, Deshmukh M, Venkatesh A, Tan PS, Sun X. A genomic and clinical prognostic index for hepatitis C-related early-stage cirrhosis that predicts clinical deterioration. Gut. 2015;64:1296-1302. [PMID: 25143343 DOI: 10.1136/gutjnl-2014-307862] [Cited by in Crossref: 40] [Cited by in F6Publishing: 45] [Article Influence: 5.0] [Reference Citation Analysis]
68 Nakao H, Yoneda M. Liver stiffness measurement using transient elastography and hepatocellular carcinoma. Hepatol Res 2011;41:921-4. [PMID: 21951870 DOI: 10.1111/j.1872-034X.2011.00895.x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
69 Schmid P, Bregenzer A, Huber M, Rauch A, Jochum W, Müllhaupt B, Vernazza P, Opravil M, Weber R. Progression of Liver Fibrosis in HIV/HCV Co-Infection: A Comparison between Non-Invasive Assessment Methods and Liver Biopsy. PLoS One. 2015;10:e0138838. [PMID: 26418061 DOI: 10.1371/journal.pone.0138838] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.7] [Reference Citation Analysis]
70 Thu Thuy PT, Bunchorntavakul C, Tan Dat H, Rajender Reddy K. A randomized trial of 48 versus 24 weeks of combination pegylated interferon and ribavirin therapy in genotype 6 chronic hepatitis C. J Hepatol. 2012;56:1012-1018. [PMID: 22266603 DOI: 10.1016/j.jhep.2011.12.020] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
71 Shah AG, Smith PG, Sterling RK. Comparison of FIB-4 and APRI in HIV-HCV coinfected patients with normal and elevated ALT. Dig Dis Sci 2011;56:3038-44. [PMID: 21526398 DOI: 10.1007/s10620-011-1710-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
72 Gabr SA, Alghadir AH. Prediction of fibrosis in hepatitis C patients: assessment using hydroxyproline and oxidative stress biomarkers. Virusdisease 2014;25:91-100. [PMID: 24426315 DOI: 10.1007/s13337-013-0182-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
73 Abd El-Meguid M, Dawood RM, Mokhles MA, El Awady MK. Extrahepatic Upregulation of Transforming Growth Factor Beta 2 in HCV Genotype 4-Induced Liver Fibrosis. J Interferon Cytokine Res 2018;38:341-7. [PMID: 30130153 DOI: 10.1089/jir.2018.0045] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
74 Groessl EJ, Liu L, Ho SB, Kanwal F, Gifford AL, Asch SM. National patterns and predictors of liver biopsy use for management of hepatitis C. J Hepatol 2012;57:252-9. [PMID: 22521358 DOI: 10.1016/j.jhep.2012.03.021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
75 Gaia S, Carenzi S, Barilli AL, Bugianesi E, Smedile A, Brunello F, Marzano A, Rizzetto M. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis. J Hepatol. 2011;54:64-71. [PMID: 20932598 DOI: 10.1016/j.jhep.2010.06.022] [Cited by in Crossref: 158] [Cited by in F6Publishing: 152] [Article Influence: 13.2] [Reference Citation Analysis]
76 Bardou-Jacquet E, Legros L, Soro D, Latournerie M, Guillygomarc’h A, Lan CL, Brissot P, Guyader D, Moirand R. Effect of alcohol consumption on liver stiffness measured by transient elastography. World J Gastroenterol 2013; 19(4): 516-522 [PMID: 23382630 DOI: 10.3748/wjg.v19.i4.516] [Cited by in CrossRef: 46] [Cited by in F6Publishing: 40] [Article Influence: 5.1] [Reference Citation Analysis]
77 Gara N, Zhao X, Kleiner DE, Liang TJ, Hoofnagle JH, Ghany MG. Discordance among transient elastography, aspartate aminotransferase to platelet ratio index, and histologic assessments of liver fibrosis in patients with chronic hepatitis C. Clin Gastroenterol Hepatol. 2013;11:303-8.e1. [PMID: 23142332 DOI: 10.1016/j.cgh.2012.10.044] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
78 Schiavon LL, Narciso-Schiavon JL, Carvalho-Filho RJ. Non-invasive diagnosis of liver fibrosis in chronic hepatitis C. World J Gastroenterol 2014; 20(11): 2854-2866 [PMID: 24659877 DOI: 10.3748/wjg.v20.i11.2854] [Cited by in CrossRef: 47] [Cited by in F6Publishing: 44] [Article Influence: 5.9] [Reference Citation Analysis]
79 Hines CD, Lindstrom MJ, Varma AK, Reeder SB. Effects of postprandial state and mesenteric blood flow on the repeatability of MR elastography in asymptomatic subjects. J Magn Reson Imaging. 2011;33:239-244. [PMID: 21182146 DOI: 10.1002/jmri.22354] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 3.5] [Reference Citation Analysis]
80 Ladero JM. Noninvasive evaluation of liver fibrosis in patients with chronic hepatitis C. Hepat Mon 2011;11:698-700. [PMID: 22235211 DOI: 10.5812/kowsar.1735143X.738] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
81 Nishikawa H, Osaki Y. Liver Cirrhosis: Evaluation, Nutritional Status, and Prognosis. Mediators Inflamm. 2015;2015:872152. [PMID: 26494949 DOI: 10.1155/2015/872152] [Cited by in Crossref: 51] [Cited by in F6Publishing: 42] [Article Influence: 7.3] [Reference Citation Analysis]
82 Bhogal H, Sterling RK. Staging of liver disease: which option is right for my patient? Infect Dis Clin North Am. 2012;26:849-861. [PMID: 23083819 DOI: 10.1016/j.idc.2012.08.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
83 Everson GT, Shiffman ML, Hoefs JC, Morgan TR, Sterling RK, Wagner DA, Lauriski S, Curto TM, Stoddard A, Wright EC; HALT-C Trial Group. Quantitative liver function tests improve the prediction of clinical outcomes in chronic hepatitis C: results from the Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial. Hepatology. 2012;55:1019-1029. [PMID: 22030902 DOI: 10.1002/hep.24752] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 4.1] [Reference Citation Analysis]
84 Vali B, Jones RB, Sakhdari A, Sheth PM, Clayton K, Yue FY, Gyenes G, Wong D, Klein MB, Saeed S. HCV-specific T cells in HCV/HIV co-infection show elevated frequencies of dual Tim-3/PD-1 expression that correlate with liver disease progression. Eur J Immunol. 2010;40:2493-2505. [PMID: 20623550 DOI: 10.1002/eji.201040340] [Cited by in Crossref: 69] [Cited by in F6Publishing: 73] [Article Influence: 5.8] [Reference Citation Analysis]
85 Donepudi I, Paredes A, Hubbard S, Awad C, Sterling RK. Utility of evaluating HCV in an uninsured population. Dig Dis Sci 2015;60:1092-7. [PMID: 25371153 DOI: 10.1007/s10620-014-3416-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
86 Tai DI, Tsay PK, Jeng WJ, Weng CC, Huang SF, Huang CH, Lin SM, Chiu CT, Chen WT, Wan YL. Differences in liver fibrosis between patients with chronic hepatitis B and C: evaluation by acoustic radiation force impulse measurements at 2 locations. J Ultrasound Med 2015;34:813-21. [PMID: 25911714 DOI: 10.7863/ultra.34.5.813] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
87 Li S, Liu X, Wei L, Wang H, Zhang J, Wei H, Qian X, Jiang Y, He F. Plasma biomarker screening for liver fibrosis with the N-terminal isotope tagging strategy. Sci China Life Sci 2011;54:393-402. [PMID: 21574042 DOI: 10.1007/s11427-011-4165-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]